U heeft thema's geselecteerd om te volgen, maar deze worden niet opgeslagen zolang u niet bent ingelogd. Login of registreer om deze thema's te blijven volgen.

Innovative Medicines Initiative (IMI): 8th Call for proposals (H2020-JTI-IMI2-2015-08-single-stage)



Action Types:

  • RIA – Research and Innovation Action


  • Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks

Please read the IMI2 Call 8 Topics Text for full details of the topic, including the breakdown and the General Conditions for the Call for proposals.

This call for proposals is continuously open for a period of two years with the following cut-off dates for submission of proposals: 16 March 2016, 15 September 2016, 16 March 2017, 14 September 2017, 15 March 2018.


  • The indicative financial contribution from the IMI2 JU for the entire period of 2 years will be a maximum of EUR 70 000 000.
  • The entire budget for this call will be available as from the first cut-off date. Three months prior to each subsequent cut-off date, the amount of the remaining budget will be published on the IMI website.


List of countries and applicable rules for funding

By way of derogation from Article 10(1) of Regulation (EU) No 1290/2013, only the following participants shall be eligible for funding from the Innovative Medicines Initiative 2 Joint Undertaking:

a) legal entities established in a Member State or an associated country, or created under Union law; and

b) which fall within one of the following categories:

i. micro, small and medium-sized enterprises and other companies with an annual turnover of EUR 500 million or less, the latter not being affiliated entities of companies with an annual turnover of more than 500 million; the definition of ‘affiliated entities’ within the meaning of Article 2(1)(2) of Regulation (EU) No 1290/2013 shall apply mutatis mutandis;

ii. secondary and higher education establishments;

iii. non-profit organisations, including those carrying out research or technological development as one of their main objectives or those that are patient organisations.

c) the Joint Research Centre;

d) international European interest organisations.

In accordance with Article 10(2) point (a) of the Regulation (EU) No 1290/2013, in case of participating legal entity established in a third country, that is not eligible for funding according to point (a) above, funding from the IMI2 JU may be granted provided the participation is deemed essential for carrying out the action by the IMI2 JU.

Meer info:

Info & contact

Link naar de call-webpagina

Webinars on IMI 2 Calls 7 & 8 (11 januari - 29 januari 2016)

Contactgegevens IMI Programme Office:

​Contactgegevens Nationaal Contacpunt:

Jouw VLEVA-contact voor dit thema

Maak een account aan

Volg ons